image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Hollywood Bowl - Broker price target 440p

August 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BOWL
  • Price:
  • 307p
Solid interims from Hollywood Bowl with revenues up 8.1% to £119m and EBITDA increasing 10% to £38.6m due to strong cost control, leaving full year expectations unchanged. In the UK (71 centres) revenues surpassed £100m for the first time with like-for-like sales up 1.3% year-on-year (including +3.2% increase in spend per game). There were three refurbishments (Watford, Stockton, Cardiff) and one acquisition & refurb (Lincoln). Management expect at least three openings each year, with a healthy pipeline of a further six centres signed. In Canada (11 centres), revenues rose a sparkling 47% (8% like-for-like) to £15.9m. There were two acquisitions in Guelph Ontario and Vancouver with a further two acquired post period end ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author